JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
JW (Cayman) Therapeutics Co. Ltd has announced the grant of 2,039,144 share options and 669,572 restricted share units to two grantees, including an executive Director and an employee. The options can be exercised at HK$1.32 per share, which is based on recent closing prices, and have a ten-year exercise period. The grants are part of the company’s Post-IPO Incentivization and Restricted Share Unit Schemes, aimed at incentivizing key members of the company.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
